Rituxan

Rituxan is a medication used for the treatment of Non-Hodgkin’s Lymphoma (NHL) Chronic Lymphocytic Leukemia (CLL) Rheumatoid Arthritis (RA) and Microscopic Polyangiitis (MPA).

To treat Non-Hodgkin’s Lymphoma, Rituxan can be taken alone or with other chemotherapy medicines. Rituxan should be paired up with the chemotherapy medicines, fludarabine and cyclophosphamide, to treat Chronic Lymphocytic Leukemia. If taken with methotrexate, Rituxan can reduce signs and symptoms of Rheumatoid Arthritis and slow the progression of this disease in adult patients.

Rituxan is administered intravenously and infusion time usually lasts between 3-4 hours. Most patients receive a dose twice in a month, every 15 days, and then repeated again six months later.